Originally appeared on E! Online Jelly Roll may have just gotten the favor he needed. The ...

Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the impact of mass layoffs at the FDA, impact on ...

Explore the impact of 3D models in drug discovery and how they enhance predictive insights in pre-clinical research.

The FDA is phasing out animal testing and moving to more human-relevant methods. This was announced as one of Marty Makary’s ...

Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing ...

STAT reporters chat about pharma tariffs, the latest recovery in biotech stocks, and disappointing data from a Bristol Myers ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

On Crowncast, Enrico Pesenti explains how cancer drug resistance forms and how advanced technologies are helping researchers ...

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

DHA R&D-MRDC researchers are applying the latest regulatory guidance related to AI to better carry out their mission to develop life-saving medicines.

Last week, Pfizer announced that it would no longer develop danuglipron, a daily GLP-1 weight-loss drug which investors were ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...